166 related articles for article (PubMed ID: 26499771)
1. Case vignettes based on EQ-5D to elicit stated preferences for health services utilization from the insurees' perspective.
Eckert J; Lichters M; Piedmont S; Vogt B; Robra BP
BMC Health Serv Res; 2015 Oct; 15():481. PubMed ID: 26499771
[TBL] [Abstract][Full Text] [Related]
2. Insurees' preferences in hospital choice-A population-based study.
Schuldt J; Doktor A; Lichters M; Vogt B; Robra BP
Health Policy; 2017 Oct; 121(10):1040-1046. PubMed ID: 28823608
[TBL] [Abstract][Full Text] [Related]
3. The EQ-5D-5L Valuation study in Thailand.
Pattanaphesaj J; Thavorncharoensap M; Ramos-Goñi JM; Tongsiri S; Ingsrisawang L; Teerawattananon Y
Expert Rev Pharmacoecon Outcomes Res; 2018 Oct; 18(5):551-558. PubMed ID: 29958008
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K
Value Health; 2016; 19(5):648-54. PubMed ID: 27565282
[TBL] [Abstract][Full Text] [Related]
5. Valuing EQ-5D-5L health states 'in context' using a discrete choice experiment.
Cole A; Shah K; Mulhern B; Feng Y; Devlin N
Eur J Health Econ; 2018 May; 19(4):595-605. PubMed ID: 28569351
[TBL] [Abstract][Full Text] [Related]
6. Using Discrete Choice Experiments with Duration to Model EQ-5D-5L Health State Preferences.
Mulhern B; Bansback N; Hole AR; Tsuchiya A
Med Decis Making; 2017 Apr; 37(3):285-297. PubMed ID: 27681988
[TBL] [Abstract][Full Text] [Related]
7. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
Feng Y; Devlin N; Herdman M
Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
[TBL] [Abstract][Full Text] [Related]
8. [Measuring preferences for depressive health states].
König HH; Bernert S; Angermeyer MC
Psychiatr Prax; 2005 Apr; 32(3):122-31. PubMed ID: 15818528
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
10. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
[TBL] [Abstract][Full Text] [Related]
11. A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states.
Norman R; Cronin P; Viney R
Appl Health Econ Health Policy; 2013 Jun; 11(3):287-98. PubMed ID: 23649892
[TBL] [Abstract][Full Text] [Related]
12. Does the EQ-5D measure quality of life in schizophrenia?
Halling Hastrup L; Nordentoft M; Hjorthøj C; Gyrd-Hansen D
J Ment Health Policy Econ; 2011 Dec; 14(4):187-96. PubMed ID: 22345360
[TBL] [Abstract][Full Text] [Related]
13. Relative importance of the EQ-5D five dimensions among patients with chronic diseases in South Korea - a comparison with the general population preference weights.
Hong J
Health Qual Life Outcomes; 2018 Aug; 16(1):159. PubMed ID: 30075726
[TBL] [Abstract][Full Text] [Related]
14. Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30.
van Dongen-Leunis A; Redekop WK; Uyl-de Groot CA
Value Health; 2016; 19(6):834-843. PubMed ID: 27712712
[TBL] [Abstract][Full Text] [Related]
15. Determinants of health-related quality of life in Iranian adults: evidence from a cross-sectional study.
Rezaei S; Hajizadeh M; Kazemi A; Khosravipour M; Khosravi F; Rezaeian S
Epidemiol Health; 2017; 39():e2017038. PubMed ID: 28823119
[TBL] [Abstract][Full Text] [Related]
16. Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states.
Rand-Hendriksen K; Augestad LA
Value Health; 2012; 15(5):777-82. PubMed ID: 22867789
[TBL] [Abstract][Full Text] [Related]
17. Dutch Tariff for the Five-Level Version of EQ-5D.
M Versteegh M; M Vermeulen K; M A A Evers S; de Wit GA; Prenger R; A Stolk E
Value Health; 2016 Jun; 19(4):343-52. PubMed ID: 27325326
[TBL] [Abstract][Full Text] [Related]
18. [Health Status of the German population: results of a representative survey using the EuroQol questionnaire].
König HH; Bernert S; Angermeyer MC
Gesundheitswesen; 2005 Mar; 67(3):173-82. PubMed ID: 15789280
[TBL] [Abstract][Full Text] [Related]
19. Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments.
Purba FD; Hunfeld JAM; Timman R; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV
Value Health; 2018 Oct; 21(10):1243-1249. PubMed ID: 30314626
[TBL] [Abstract][Full Text] [Related]
20. Selecting Bolt-on Dimensions for the EQ-5D: Testing the Impact of Hearing, Sleep, Cognition, Energy, and Relationships on Preferences Using Pairwise Choices.
Finch AP; Brazier J; Mukuria C
Med Decis Making; 2021 Jan; 41(1):89-99. PubMed ID: 33256502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
